That starts with reducing prescription drug costs for seniors
Reduce prescription drug costs for seniors.
Occurrences
Evidence
Arizona families deserve a health care system that works for everyone--regardless of one’s income or zip code. That starts with reducing prescription drug costs for seniors, capping insulin at just $35 a month, cracking down on fraud and waste in Medicare’s hospice networks, expanding access to quality healthcare services in the Valley, and protecting insurance coverage for pre-existing conditions.
On Aug. 12, 2022, the House voted on H. Res. 1316, providing for consideration of the Senate amendment to H.R. 5376, the Inflation Reduction Act. The roll call shows Greg Stanton (AZ) voted Yea.
The Inflation Reduction Act’s subtitle on prescription drug pricing reform requires CMS to negotiate the prices of certain prescription drugs under Medicare beginning in 2026 and sets a process for negotiating 10 drugs in 2026, 15 in 2027, 15 in 2028, and 20 in 2029 and beyond.
CMS announced negotiated prices for 10 drugs under Medicare Part D that will go into effect beginning January 1, 2026, and said projected savings for people with Medicare Part D coverage would be an estimated $1.5 billion.
"With today’s vote, Congress has delivered on two long-kept promises: to cut drug costs for families and seniors... I have pushed hard to allow Medicare to use its negotiating power to lower prescription drug prices since my first day in Congress."
CMS says the Inflation Reduction Act gave Medicare authority to negotiate prices for 10 Part D drugs, that the negotiated prices take effect on January 1, 2026, and that people with Medicare Part D coverage are projected to save an estimated $1.5 billion.
HHS/CMS announced 15 more drugs selected for Medicare price negotiations and said the first-cycle negotiated prices would become effective in 2026, with expected out-of-pocket savings for Medicare Part D enrollees.
The House roll call on H. Res. 1316, the procedural vote for H.R. 5376, shows Greg Stanton (AZ) voting Yea on the Inflation Reduction Act vehicle.
Assessments
Stanton’s promise was substantially fulfilled through the Inflation Reduction Act enacted in August 2022 during the same House term tied to his 2020 campaign. That law created Medicare drug price negotiation and other senior-focused prescription drug cost reductions, and Stanton cast a recorded vote to advance the bill while publicly claiming he had pushed for Medicare negotiation since entering Congress. He was not the sole driver of the policy, but as a federal legislator he materially contributed to passage of the enacted measure that delivered the promised outcome. Later CMS implementation in 2024-2026 confirms the reductions took effect, but the key legislative delivery occurred during his same term.
Stanton promised to reduce prescription drug costs for seniors in the federal House context. During the 117th Congress after the 2020 election, he voted for and publicly advocated the Inflation Reduction Act, which was enacted in August 2022 and created major Medicare prescription drug cost reforms, including Medicare drug price negotiation and related senior drug-cost protections. Although some savings take effect in later years, the core policy was passed during the same House term covered by the campaign context, so this counts as delivered with same_term timing.